These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3728504)

  • 1. Efficacy of platelet transfusions in immune thrombocytopenia.
    Carr JM; Kruskall MS; Kaye JA; Robinson SH
    Am J Med; 1986 Jun; 80(6):1051-4. PubMed ID: 3728504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia in the newborn.
    Gill FM
    Semin Perinatol; 1983 Jul; 7(3):201-12. PubMed ID: 6359431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of severe thrombocytopenia in a pregnant patient with rhesus-negative blood with autoimmune thrombocytopenic purpura after intravenous rhesus immune globulin.
    Moise KJ; Cano LE; Sala DJ
    Am J Obstet Gynecol; 1990 May; 162(5):1237-8. PubMed ID: 2160193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
    Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
    J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates.
    Hoque MM; Rahman M; Rahman SM; Habibullah MM; Faruki MA; Rahman KH; Mamun AA; Hossain MA
    Mymensingh Med J; 2013 Jan; 22(1):64-8. PubMed ID: 23416811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
    Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
    Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myths about platelet transfusions in immune-mediated thrombocytopenias.
    Thachil J
    Br J Haematol; 2010 Aug; 150(4):494-5. PubMed ID: 20507308
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.
    Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM
    Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.
    van der Lugt NM; van Kampen A; Walther FJ; Brand A; Lopriore E
    Vox Sang; 2013 Oct; 105(3):236-43. PubMed ID: 23782272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenias.
    Aster RH
    Hosp Pract (Off Ed); 1983 Nov; 18(11):187-90, 194-5, 198-9 passim. PubMed ID: 6414933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transfusion platelet responses in critically ill cancer patients with hypoproliferative thrombocytopenia.
    Baron E; Charpentier J; François A; Ben Hadj Amor H; Habr B; Cariou A; Chiche JD; Mira JP; Jamme M; Pène F
    Transfusion; 2020 Feb; 60(2):275-284. PubMed ID: 31724828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new IVIgG preparation (IVIgG pH 4.25): preliminary results for the treatment of immune thrombocytopenia.
    Joyner M; Lee R; Hegde UM
    J Infect; 1987 Jul; 15 Suppl 1():51-4. PubMed ID: 3117900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous immunoglobulin for post-transfusion purpura.
    Becker T; Panzer S; Maas D; Kiefel V; Sprenger R; Kirschbaum M; Mueller-Eckhardt C
    Br J Haematol; 1985 Sep; 61(1):149-55. PubMed ID: 4052323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives of platelet transfusions: defining the optimal dose.
    Strauss RG
    J Clin Apher; 1995; 10(3):124-7. PubMed ID: 8582893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram-induced bleeding due to severe thrombocytopenia.
    Andersohn F; Konzen C; Bronder E; Klimpel A; Garbe E
    Psychosomatics; 2009; 50(3):297-8. PubMed ID: 19567773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe thrombocytopenia refractory to platelet transfusions, secondary to abciximab readministration, in a patient previously diagnosed with idiopathic thrombocytopenic purpura. A possible etiopathogenic link].
    Méndez TC; Díaz O; Enríquez L; Baz JA; Fernández F; Goicolea J
    Rev Esp Cardiol; 2004 Aug; 57(8):789-91. PubMed ID: 15282070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon.
    Proctor SJ; Jackson G; Carey P; Stark A; Finney R; Saunders P; Summerfield G; Maharaj D; Youart A
    Blood; 1989 Nov; 74(6):1894-7. PubMed ID: 2804339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fetal weight-adjusted intrauterine IgG therapy in neonatal alloimmune thrombocytopenia].
    Giers G; Hoch J; Bald R; Bauer H; Kroll H; Kiefel V; Scharf RE; Hanfland P; Hansmann M; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1996; 33():160-4. PubMed ID: 8974690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.